Skip to main content

Table 2 Antibacterial activity of sw-5 (serrawettin W2) produced by YD25T

From: Analysis of the genomic sequences and metabolites of Serratia surfactantfaciens sp. nov. YD25T that simultaneously produces prodigiosin and serrawettin W2

Bacteria

Drug resistance

Inhibitory zone

1

2

3

4

5

6

7

8

9

diameter (mm)

Staphylococcus aureu A1

R

R

R

R

R

R

R

-

-

NI

Staphylococcus aureu A2

R

S

S

R

R

R

R

-

-

SI

Staphylococcus aureu A3

S

R

S

S

R

S

S

-

-

NI

Staphylococcus aureu A4

R

R

R

R

R

R

R

-

-

NI

Staphylococcus aureu A5

R

R

R

R

R

R

R

-

-

SI

Staphylococcus aureu A6

R

R

R

R

R

R

R

-

-

SI

Staphylococcus aureu B1

S

R

S

R

R

S

S

-

-

NI

Staphylococcus aureu B2

R

R

R

R

R

R

R

-

-

SI

Staphylococcus aureu B3

R

R

R

R

R

R

R

-

-

NI

Staphylococcus aureu B4

S

R

S

S

R

S

S

-

-

NI

Staphylococcus aureu B5

S

S

S

S

R

S

S

-

-

SI

Staphylococcus aureu B6

S

S

S

S

S

S

S

-

-

SI

Staphylococcus aureu C1

R

R

R

R

R

R

R

-

-

NI

Staphylococcus aureu C2

R

R

R

R

R

R

R

-

-

SI

Staphylococcus aureu C3

S

R

S

S

R

I

S

-

-

11.2 ± 0.4

Staphylococcus aureu C4

R

R

R

R

R

R

R

-

-

SI

Staphylococcus aureu C5

R

R

R

R

R

R

R

-

-

SI

Staphylococcus aureu C6

S

R

S

S

R

S

S

-

-

9.2 ± 0.3

Staphylococcus aureu D1

R

S

R

R

R

R

R

-

-

NI

Staphylococcus aureu D2

S

R

S

S

R

S

S

-

-

7.6 ± 0.4

Staphylococcus aureu D3

R

R

R

R

R

R

R

-

-

SI

Staphylococcus aureu D4

R

R

R

R

R

R

R

-

-

NI

Staphylococcus aureu D5

R

R

S

R

R

R

R

-

-

8.5 ± 0.5

Staphylococcus aureu D6

R

S

S

R

R

R

R

-

-

SI

Staphylococcus aureu E1

S

R

S

R

R

S

S

-

-

11.2 ± 0.3

Staphylococcus aureu E2

R

S

R

R

R

R

R

-

-

SI

Staphylococcus aureu E3

-

-

-

S

-

S

S

R

R

8.3 ± 0.2

Staphylococcus aureu E4

-

-

-

-

-

S

S

R

R

11.4 ± 0.4

Staphylococcus aureu E5

S

I

S

S

R

S

S

-

-

10.1 ± 0.3

Staphylococcus aureu E6

S

R

S

S

R

S

S

-

-

8.1 ± 0.4

Escherichia coli 44102

-

-

-

-

-

-

-

-

-

NI

Pseudomonas aeruginosa A62

-

-

-

-

-

-

-

-

-

14.4 ± 0.4

Bacillus subtilis A47

-

-

-

-

-

-

-

-

-

SI

Rhodococcus rhodochrous

-

-

-

-

-

-

-

-

-

12.5 ± 0.3

CGMCC 4.1815

          

Enterococcus faecium

-

-

-

-

-

-

-

-

-

NI

CGMCC 1.2025

          

Klebsiella pneumoniae

-

-

-

-

-

-

-

-

-

NI

CGMCC 1.10617

          

Psychrobacter faecalis

-

-

-

-

-

-

-

-

-

NI

CGMCC 1.10869

          

Acinetobacter baumannii

-

-

-

-

-

-

-

-

-

NI

CGMCC 1.6769

          

Shigella dysenteriae

-

-

-

-

-

-

-

-

-

10.5 ± 0.5

CGMCC 1.1869

          

Micrococcus luteus

-

-

-

-

-

-

-

-

-

19.4 ± 0.5

CGMCC 1.2299

          
  1. 1, prostaphlin (10 units); 2, clindamycin (2 μg); 3, rifampicin (5 μg); 4, levofloxacin (5 μg); 5, erythromycin (15 μg); 6, amikacin (30 μg); 7, cefazolin (30 μg); 8, paediatric compound sulfamethoxazole tablets (23.75 μg); 9, ampicillin (10 μg). R, resistance to the antibiotic; S, sensitive to the antibiotic; I, intermediate; “-”, not determined. NI, no inhibition; SI, slight inhibition. SI indicated the diameter of the inhibition zone was less than 7 mm. The diameter of the control was 6 mm. Numbers show an average of three replications